Angiosoma Overview
- Status
-
Public
- Employees
-
1
- Stock Symbol
-
GSTC
- Investments
-
1
Angiosoma General Information
Description
GlobeStar Therapeutics Corp is a clinical-stage Pharmaceutical Company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing innovative therapies for people with serious and life-threating rare disorders.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
PINX
Primary Office
- 14001 Walden Road
- Suite 600
- Montgomery, TX 77356
- United States
+1 (832) 000-0000
Angiosoma Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.25M | 643M | 4.32M | -$0.02 |
Angiosoma Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 |
|---|---|---|---|---|
| EV | 4,750 | 16,246 | 2,670 | 4,034 |
| Revenue | 0 | 0 | 0 | 1 |
| EBITDA | (9,647) | (9,513) | (302) | (314) |
| Net Income | (9,803) | (9,802) | (542) | (675) |
| Total Assets | 1 | 6 | 90 | 142 |
| Total Debt | 20 | 106 | 155 | 114 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Angiosoma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Angiosoma Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Alex Blankenship | President & Chief Executive Officer | ||
| Brooke Greenwald | Chief Marketing Officer |
Angiosoma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Angiosoma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Angiosoma Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 00000 | 07-Jun-2016 | 0000000000 | Energy Exploration |